Nova Advances Autism Research with Unique Psilocybin Microdosing Health Canada Approved Trial
Nova Mentis has been setting the stage over the past several years for a potentially ground-breaking trial designed to provide new treatment options for the cognitive and behavioural symptoms associated
Read More »
May 26, 2023
Nova News & Insights
Nova News & Insights Our monthly e-newsletter, Nova News & Insights, is your direct source for news and information about our research and drug development program. Check out the April
Read More »
April 28, 2023
Nova News & Insights
Nova News & Insights Our monthly e-newsletter, Nova News & Insights, is your direct source for news and information about our research and drug development program. Check out the February
Read More »
March 1, 2023
Nova News & Insights
Nova News & Insights Our monthly e-newsletter, Nova News & Insights, is your direct source for news and information about our research and drug development program. Check out the January
Read More »
January 30, 2023
Why is Psilocybin Important in Autism?
Autism spectrum disorder (ASD) is the fastest growing developmental disability in the world, increasing at a rate of 10-17% each year. According to the U.S. Centers for Disease Control and
Read More »
January 26, 2023
Derek Ivany: A Brother’s Quest to Find Help
Growing up with my brother was unlike anything else. While other children had siblings to play and joke around with, I had a brother who seemed like he lived in
Read More »
January 24, 2023